MOBILIZATION OF PERIPHERAL BLOOD PROGENITORS IN MULTIPLE MYELOMA. HOW TO DEAL WITH HARD TO MOBILIZE MYELOMA PATIENTS-SIX YEARS CENTER EXPERIENCE

Journal
Haematologica, the hematology journal, Abstract book, 2007; 494
Date Issued
2007
Author(s)
Abstract
Peripheral blood progenitor cells (PBPCs) mobilized with high-dose
chemotherapy and hematopoietic growth factors are still used to support
myeloablative therapy of multiple myeloma during the autologous setting.
Variables having an impact on the ability to collect PBPC include age,
month’s prior previous chemotherapy, mobilization regimen and platelet
count at the time of mobilization. Myeloma patients with low mobilizing
capacity indicate the need of evaluating alternative mobilizing regimens.
We analyzed 25 patients with MM that underwent PBPC mobilization
at Department of hematology, University Clinical Center Skopje.
Pts received Cyclophosphamide (3gr/m2) followed by daily G-CSF (10
mcg/kg). In 15 pts we experienced a significant WBC nadir on median day
+6, and began pheresis in recovered WBC up to 5.0×109/L on day +8
(median). Good mobilizers reached at least 2×106/kg CD34+ cells with
median 3 (ranges 1-6) apheresis procedures. In 9 MM patients we registered
low mobilizing capacity. Remobilizing procedure was preformed
with single G-CSF in a dose of 20 mcg/kg in a 5 days regimen. All remobilized
patients reached sufficient CD34+/kg count with median 2
(ranges 1-4) aphaeresis procedures. In statistical data in both groups of
good and hard to mobilize MM pts we followed several variables concerning
the platelet count on day 1 of aphaeresis which correlated with
the ability to collect over 5×106 CD34+cells/kg (p<0,001), age of patients
< 60 yrs and >60yrs (p<0,001) and previously received chemotherapy
cycles of 5 pts (27%) who started aphaeresis on median day +14
(p<0,001) in the Cy/G-CSF group. We can conclude that the 5 day regimen
of single G-CSF in increased daily dose showed effective with efficient
yields results for median 2 day leukopheresis procedure, well tolerated
with possibility for mobilization in outpatient basis. This
approach, if confirmed on larger series of myeloma patients could open
new opportunities in stem cell mobilization for poor or non-mobilizers.
File(s)
Loading...
Thumbnail Image
Name

MOBILIZATION OF PERIPHERAL BLOOD PROGENITORS IN MULTIPLE MYELOMA. HOW TO DEAL WITH HARD TO MOBILIZE MYELOMA PATIENTS-SIX YEARS CENTER EXPERIENCE.pdf

Size

70.87 KB

Format

Adobe PDF

Checksum

(MD5):44a341783beb81f2ffd357b239f4387e

Loading...
Thumbnail Image
Name

12th Congress of the European Hematology Association.pdf

Size

6.81 MB

Format

Adobe PDF

Checksum

(MD5):dfeea215f9e8bd7b9e4c08c63552cbe5